1. Scrip
  2. >>Focus On Asia

Standigm Races AI Rivals To Become Global Discovery Contender

 
• By Jung Won Shin

The South Korean AI-driven drug discovery venture is vying with global rivals in the space to show concrete validation of its approaches in partnered projects, while eyeing international expansion and new fundraising, its CEO says.

AI
Pursuing Discovery Of First-In-Class, Novel Molecules • Source: Shutterstock

With a goal to offer a new standard in novel drug discovery using artificial intelligence (AI) technology, South Korea's Standigm Inc. is progressing multiple co-research projects with pharma and other partners, and is poised to establish a new laboratory facility this year to further validate the competitiveness of its AI-designed molecules.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from South Korea

More from Focus On Asia